Link Immunotherapeutics Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Out of Business
Link Immunotherapeutics General Information
Description
Developer of next-generation T-cell engaging therapies designed to treat a broad spectrum of oncology indications. The company engineers novel, highly developable immunotherapies with both more selectivity for tumor over normal tissue and more complete T-cell activation, enabling patients with good safety profiles and more durable cancer responses.
Contact Information
Website
www.linkimmunotherapeutics.comCorporate Office
- 1616 Eastlake Avenue East
- Unit 208
- Seattle, WA 98102
- United States
Corporate Office
- 1616 Eastlake Avenue East
- Unit 208
- Seattle, WA 98102
- United States
Link Immunotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 07-Dec-2024 | Completed | Out of Business | |||
| 3. Seed Round | 25-May-2023 | Completed | Startup | |||
| 2. Seed Round | 30-Mar-2022 | $14.2M | $29.2M | Completed | Startup | |
| 1. Seed Round | 30-Jun-2021 | $15M | $15M | Completed | Startup |
Link Immunotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 NV | ||||||||
| Seed-2 | ||||||||
| Seed | 10,826,471 | $0.000100 | $2.76 | $2.76 | 1x | $2.76 | 34.97% |
Link Immunotherapeutics Comparisons
Industry
Financing
Details
Link Immunotherapeutics Competitors (1)
One of Link Immunotherapeutics’s competitors is Tentarix Biotherapeutics, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tentarix Biotherapeutics | Venture Capital-Backed | San Diego, CA |
Link Immunotherapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Link Immunotherapeutics Patents
Link Immunotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3242196-A1 | Anti-mesothelin antigen-binding molecules and uses thereof | Pending | 06-Oct-2021 | ||
| EP-4413047-A1 | Anti-mesothelin antigen-binding molecules and uses thereof | Pending | 06-Oct-2021 | ||
| WO-2023060157-A1 | Anti-mesothelin antigen-binding molecules and uses thereof | Inactive | 06-Oct-2021 | A61P35/00 |
Link Immunotherapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Link Immunotherapeutics FAQs
-
When was Link Immunotherapeutics founded?
Link Immunotherapeutics was founded in 2019.
-
Where is Link Immunotherapeutics headquartered?
Link Immunotherapeutics is headquartered in Seattle, WA.
-
What is the size of Link Immunotherapeutics?
Link Immunotherapeutics has 6 total employees.
-
What industry is Link Immunotherapeutics in?
Link Immunotherapeutics’s primary industry is Biotechnology.
-
Is Link Immunotherapeutics a private or public company?
Link Immunotherapeutics is a Private company.
-
What is Link Immunotherapeutics’s current revenue?
The current revenue for Link Immunotherapeutics is .
-
How much funding has Link Immunotherapeutics raised over time?
Link Immunotherapeutics has raised $51.2M.
-
Who are Link Immunotherapeutics’s competitors?
Tentarix Biotherapeutics is a competitor of Link Immunotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
